Your browser doesn't support javascript.
loading
Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): a randomised, double-blinded, placebo-controlled, phase 3 trial.
Xia, Zhongjun; Leng, Yun; Fang, Baijun; Liang, Yang; Li, Wei; Fu, Chengcheng; Yang, Linhua; Ke, Xiaoyan; Jiang, Hua; Weng, Jianyu; Liu, Li; Zhao, Yaozhong; Zhang, Xuejun; Huang, Zhongxia; Liu, Aichun; Shi, Qingzhi; Gao, Yuhuan; Chen, Xiequn; Pan, Ling; Cai, Zhen; Wang, Zhao; Wang, Yafei; Fan, Yaqun; Hou, Ming; Ma, Yigai; Hu, Jianda; Liu, Jing; Zhou, Jianfeng; Zhang, Xiaohong; Meng, Haitao; Lu, Xuzhang; Li, Fei; Ren, Hanyun; Huang, Bintao; Shao, Zonghong; Zhou, Hebing; Hu, Yu; Yang, Shifang; Zheng, Xiangjun; Wei, Peng; Pang, Hongyan; Yu, Wei; Liu, Yuzhang; Gao, Sujun; Yan, Lingzhi; Ma, Yanping; Jing, Hongmei; Du, Juan; Ling, Wei; Zhang, Jingyi.
Affiliation
  • Xia Z; Department of Hematologic Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China.
  • Leng Y; Department of Hematology, Beijing Chao-Yang Hospital Capital Medical University, Beijing, China.
  • Fang B; Department of Hematology, Henan Cancer Hospital, Henan Cancer Hospital Affiliated to Zhengzhou University, Zhengzhou, China.
  • Liang Y; Department of Hematologic Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China.
  • Li W; Department of Hematology, The First Hospital of Jilin University, Changchun, China.
  • Fu C; Department of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology National Clinical Research Center for Hematologic Diseases, Suzhou, China.
  • Yang L; Department of Hematology, Second Hospital of Shanxi Medical University, Taiyuan, China.
  • Ke X; Department of Hematology and Lymphoma Research Center, Peking University Third Hospital, Beijing, China.
  • Jiang H; Department of Hematology, Changzheng Hospital, Second Military Medical University, Shanghai, China.
  • Weng J; Department of Hematology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Liu L; Department of Hematology, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.
  • Zhao Y; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
  • Zhang X; Department of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
  • Huang Z; Department of Hematology, Beijing Chao-Yang Hospital Capital Medical University, Beijing, China.
  • Liu A; Department of Hematology, Harbin Medical University Cancer Hospital, Harbin, China.
  • Shi Q; Department of Hematology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
  • Gao Y; Department of Hematology, Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • Chen X; Department of Hematology, XiJing Hospital, Fourth Military Medical University, Xi'an, China.
  • Pan L; Department of Hematology, West China Hospital, Sichuan University, Chengdu, China.
  • Cai Z; Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • Wang Z; Department of Hematology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • Wang Y; Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
  • Fan Y; Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, Medical College of Xiamen University, Xiamen, China.
  • Hou M; Department of Hematology, Qilu Hospital of Shandong University, Jinan, China.
  • Ma Y; Department of Hematology, China-Japan Friendship Hospital, Beijing, China.
  • Hu J; Fujian Medical University Union Hospital, Fujian Institute of Hematology, Fujian Province Key Laboratory of Hematology, Fuzhou, China.
  • Liu J; Department of Hematology, The Third Xiangya Hospital of Central South University, Changsha, China.
  • Zhou J; Department of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Zhang X; Department of Hematology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
  • Meng H; Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • Lu X; Department of Hematology, The Affiliated Changzhou No.2 People's Hospital of Nanjing Medical University, Changzhou, China.
  • Li F; Department of Hematology, First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Ren H; Department of Hematology, Peking University First Hospital, Beijing, China.
  • Huang B; Department of Hematology, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.
  • Shao Z; Department of Hematology, General Hospital of Tianjin Medical University, Tianjin, China.
  • Zhou H; Department of Hematology, Beijing Luhe Hospital, Capital Medical University, Beijing, China.
  • Hu Y; Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wunan, China.
  • Yang S; Beijing Sunbio Biotech Co., Ltd., Beijing, China.
  • Zheng X; Beijing Sunbio Biotech Co., Ltd., Beijing, China.
  • Wei P; Beijing Sunbio Biotech Co., Ltd., Beijing, China.
  • Pang H; Beijing Sunbio Biotech Co., Ltd., Beijing, China.
  • Yu W; Beijing Sunbio Biotech Co., Ltd., Beijing, China.
  • Liu Y; Department of Hematology, Henan Cancer Hospital, Henan Cancer Hospital Affiliated to Zhengzhou University, Zhengzhou, China.
  • Gao S; Department of Hematology, The First Hospital of Jilin University, Changchun, China.
  • Yan L; Department of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology National Clinical Research Center for Hematologic Diseases, Suzhou, China.
  • Ma Y; Department of Hematology, Second Hospital of Shanxi Medical University, Taiyuan, China.
  • Jing H; Department of Hematology and Lymphoma Research Center, Peking University Third Hospital, Beijing, China.
  • Du J; Department of Hematology, Changzheng Hospital, Second Military Medical University, Shanghai, China.
  • Ling W; Department of Hematology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Zhang J; Department of Hematology, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.
BMC Cancer ; 23(1): 980, 2023 Oct 14.
Article de En | MEDLINE | ID: mdl-37838670
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Myélome multiple / Neutropénie Limites: Humans Langue: En Journal: BMC Cancer Sujet du journal: NEOPLASIAS Année: 2023 Type de document: Article Pays d'affiliation: Chine
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Myélome multiple / Neutropénie Limites: Humans Langue: En Journal: BMC Cancer Sujet du journal: NEOPLASIAS Année: 2023 Type de document: Article Pays d'affiliation: Chine